C01CA14 - Dopexamine |
Propably not porphyrinogenic |
PNP |
Rationale
Catecholamine. Non-CYP metabolism. No data pointing to CYP-interaction.
Chemical description
Catecholamine.
Therapeutic characteristics
Synthetic catecholamine used in intravenous short-duration treatment of chronic heart failure. Administered in infusion 1-6 ug/kg/minute in 0.9 %NaCl or 5% glucose solution.
Metabolism and pharmacokinetics
Metabolized in the liver via O-methylation and O-sulfatation of the catechol hydroxyl group. Half time in blood 6-7 minutes.
Similar drugs
© NAPOS 2024